Sudeep Pharma’s IPO, which closes today, has garnered attention for its grey market premium, allotment timeline, and potential listing price. Shares are currently trading at Rs 86 per share, indicating a potential listing price of Rs 679 and an estimated 14.5% upside over the issue price of Rs 593. The company is expected to have a successful listing.